Hyasynth Bio
Montréal
About Hyasynth Bio
We’re a bioengineering company that's reducing the massive environmental footprint of the CBD market through precision fermentation. And our technology never touches a plant. CBD is a global $12Bn consumer market and Hyasynth's precision fermentation platform eliminates wasteful plant cultivation and decreases the carbon impact by more than 97%. Hyasynth is the world's only bioengineering company with a scalable, fermentation process for CBD that is cost-efficient and regulatory-compliant.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.2M
- Last round: Debt Financing (Dec 2021)
- Website: hyasynthbio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Cannabis, Cosmetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/hyasynth-bio-48214 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.